EU Clinical Trial 2018-003958-25

Screening for cancer with PET / CT in patients with unprovoked venous thromboembolic disease with a high risk of developing cancer. Open randomized clinical trial.  May 22, 2019

Main objective of the trial: Estimate the impact of an active cancer search strategy using PET-CT in the number of neoplasms diagnosed in the screening process in patients with high-risk unprovoked thromboembolic disease. Estimar el impacto de una estrategia de búsqueda activa de cáncer mediante PET-TAC en el número de neoplasias diagnosticadas en el proceso de cribado en pacientes con enfermedad tromboembólica no provocada de alto riesgo.

Parties

Investigators
Sponsors
Countries
ES
Keywords
FLUDEOXYGLUCOSE (18F) Fludesoxiglucosa (18F) Fludesoxiglucosa (18F)- IBA

JSON preview

Similar records

Title

Source:  EMA Last updated:  May 30, 2019

From ClinicalTrialsRegister.eu, a database of the European Medicines Agency. This record may not reflect the most current and accurate data available from the EMA.